JPH01503436A - 少数ライノウイルスレセプターグループのレセプター - Google Patents

少数ライノウイルスレセプターグループのレセプター

Info

Publication number
JPH01503436A
JPH01503436A JP63503047A JP50304788A JPH01503436A JP H01503436 A JPH01503436 A JP H01503436A JP 63503047 A JP63503047 A JP 63503047A JP 50304788 A JP50304788 A JP 50304788A JP H01503436 A JPH01503436 A JP H01503436A
Authority
JP
Japan
Prior art keywords
receptor
receptors
rhinovirus
virus
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63503047A
Other languages
English (en)
Japanese (ja)
Inventor
ブラッス　ディーテル
クエッヒュラー　エルンシュト
ミシャク　ハーラルト
ノイバウエル　クリストフ
Original Assignee
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JPH01503436A publication Critical patent/JPH01503436A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Sanitary Device For Flush Toilet (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Filtering Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Golf Clubs (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP63503047A 1987-04-14 1988-04-13 少数ライノウイルスレセプターグループのレセプター Pending JPH01503436A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3712678.4 1987-04-14
DE19873712678 DE3712678A1 (de) 1987-04-14 1987-04-14 Rezeptor der kleinen rhinovirus rezeptor gruppe

Publications (1)

Publication Number Publication Date
JPH01503436A true JPH01503436A (ja) 1989-11-22

Family

ID=6325617

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63503047A Pending JPH01503436A (ja) 1987-04-14 1988-04-13 少数ライノウイルスレセプターグループのレセプター

Country Status (13)

Country Link
EP (1) EP0287076B1 (enExample)
JP (1) JPH01503436A (enExample)
AT (1) ATE87333T1 (enExample)
AU (1) AU619177B2 (enExample)
DE (2) DE3712678A1 (enExample)
ES (1) ES2054724T3 (enExample)
FI (1) FI98704C (enExample)
IE (1) IE61992B1 (enExample)
IL (1) IL86077A (enExample)
NZ (1) NZ224259A (enExample)
PT (1) PT87244B (enExample)
WO (1) WO1988008032A1 (enExample)
ZA (1) ZA882578B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341055C (en) * 1987-12-08 2000-07-18 Alan Mcclelland Transfectant cell lines which express the major human rhinovirus receptor
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
DE68929096T2 (de) 1988-09-01 2000-05-11 Bayer Corp., Pittsburgh Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
EP0468257B1 (en) * 1990-07-20 1999-09-01 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5674982A (en) * 1990-07-20 1997-10-07 Bayer Corporation Multimeric form of human rhinovirus receptor protein
AU678978B2 (en) * 1992-07-08 1997-06-19 Boehringer Ingelheim International Gmbh Receptor derivates with binding sites for human rhinoviruses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0169146A3 (en) * 1984-07-20 1988-07-20 Merck & Co. Inc. Monoclonal antibodies directed against the cellular receptor of human rhinovirus

Also Published As

Publication number Publication date
IE881110L (en) 1988-10-14
FI98704C (fi) 1997-08-11
DE3712678A1 (de) 1988-10-27
AU619177B2 (en) 1992-01-23
PT87244A (pt) 1988-05-01
EP0287076A1 (de) 1988-10-19
EP0287076B1 (de) 1993-03-24
IE61992B1 (en) 1994-12-14
NZ224259A (en) 1991-07-26
PT87244B (pt) 1992-08-31
DE3879535D1 (enExample) 1993-04-29
AU1463088A (en) 1988-10-20
FI885757A0 (fi) 1988-12-13
ZA882578B (en) 1989-12-27
ES2054724T3 (es) 1994-08-16
WO1988008032A1 (fr) 1988-10-20
IL86077A0 (en) 1988-09-30
IL86077A (en) 1994-02-27
FI885757L (fi) 1988-12-13
FI98704B (fi) 1997-04-30
ATE87333T1 (de) 1993-04-15

Similar Documents

Publication Publication Date Title
Fisher et al. Proteoglycans of developing bone.
Piessens et al. Diethylcarbamazine enhances antibody-mediated cellular adherence to Brugia malayi microfilariae
Anderson et al. Diagnosis of human parvovirus infection by dot‐blot hybridization using cloned viral DNA
Mackay et al. Early events in polyoma virus infection: attachment, penetration, and nuclear entry
AU611091B2 (en) Canine heartworm vaccine and diagnostic test
JPH01503436A (ja) 少数ライノウイルスレセプターグループのレセプター
DK163383B (da) Fremgangsmaade og reagenssystem til bestemmelse henholdsvis detektering af en bestemt polynucleotidsekvens i et testmedium indeholdende enkeltstrengede nucleinsyrer
Horner et al. Comparison of an antigen capture enzyme-linked assay with reverse transcription—polymerase chain reaction and cell culture immunoperoxidase tests for the diagnosis of ruminant pestivirus infections
Fagerhol Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein?
US5304636A (en) Receptor for the human rhinovirus minor group
Morgan et al. A structural investigation of the Epstein—Barr (EB) virus membrane antigen glycoprotein, gp340
CN1045603A (zh) 筛选系统
von Zeipel et al. A study of the association of ECHO viruses to aseptic meningitis
US5603932A (en) Receptor of the minor human rhinovirus receptor group
Prakobphol et al. Bacterial adherence on replicas of sodium dodecyl sulfate-polyacrylamide gels
McManus et al. Strain characterization in the hydatid organism, Echinococcus granulosus: current status and new perspectives
Doerder et al. Purification and Partial Characterization of the H Immobilization Antigens of Tetrahymena thermophila 1
Horzinek et al. The peplomers of Berne virus
Papanastasiou et al. The release of the variant surface protein of Giardia to its soluble isoform is mediated by the selective cleavage of the conserved carboxy-terminal domain
Moennig Characteristics of the virus
US20020187466A1 (en) Anticytomegalovirus monoclonal antibodies and processes for the in vitro diagnosis of infections by human cytomegaloviruses and a protein-kinase inducible by cytomegaloviruses and recognisable by aforesaid monoclonal antibodies
Svehag et al. Examination of virus-γM antibody complexes by electron microscopy I. Configuration of γM antibodies and mode of attachment to antigen
DE69629121T2 (de) Verwendung eines 24 kD Proteins zur Behandlung und Diagnose einer HCV Infektion
JPS6151571A (ja) オ−エスキ−病診断用抗原の単離・精製法
Richmond An interferon-like inhibitor of foot-and-mouth disease virus induced by phytohemagglutinin in swine leukocyte culturesb